ArticleBioinformation2024
Assessment of alveolar bone loss in diabetic patients with class II composite resin restorations.
Article in Bioinformation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluated the impact of Class II composite resin restorations on alveolar bone loss in diabetic patients by comparing those with restorations to a control group without such treatments at the Faculty of Dentistry, Najran University, Saudi Arabia. A total of 64 diabetic patients were divided into two groups: control group G1 (n=32) with no composite resin restorations and test group G2 (n=32) with composite resin restorations. Metrics assessed included plaque index (P.I), gingival index (G.I), HbA1c levels, and alveolar bone loss percentage. Results showed that test group G2 had higher mean values for P.I (2.73 vs. 2.51), G.I (2.53 vs. 2.22), and alveolar bone loss (48.28% vs. 44.16%) compared to control group G1. HbA1c levels were slightly lower in G2 but not significantly different. Significant differences were found in P.I, G.I, and alveolar bone loss between the groups (p-values: 2.767e-06, 2.895e-13, and 3.585e-08, respectively). Diabetic patients with composite resin restorations exhibited poorer oral hygiene, greater gingival inflammation, and increased alveolar bone loss. Enhanced preventive care and monitoring are recommended for these patients. However, clinically, this highlights the importance of careful material selection, enhanced periodontal monitoring, and tailored preventive care to prevent further bone loss and maintain oral health in diabetic patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.